•
Sep 30, 2012

Teva Q3 2012 Earnings Report

Total Revenue
$4.97B
Previous year: $4.34B
+14.5%
EPS
$1.28
Previous year: $1.03
+24.3%
Gross Profit
$2.6B
Previous year: $2.88B
-9.7%
Cash and Equivalents
$1.43B
Previous year: $1.09B
+32.0%
Free Cash Flow
$799M
Previous year: $206M
+287.9%
Total Assets
$49.6B
Previous year: $41.3B
+20.1%

Teva

Teva